The Effectiveness of the Influence of Median-Dose StatinTherapy on the Serum Lipid Profilein Patients with Stable Coronary Heart Disease, Combined with Non-Alcoholic Fatty Liver Disease at the Stage of Steatosis
Journal Title: Lviv Clinical Bulletin - Year 2018, Vol 1, Issue 21
Abstract
Introduction. Today, dyslipidaemia is considered one of the main risk factors for atherosclerosis and, as a consequence, cardiovascular disease. In turn, the liver plays a leading role in the onset of atherogenic dyslipidemia and at the same time serves as the target organ, which leads to the development of non-alcoholic fatty liver disease (NAFLD). The search of adequate hypolipidemic therapy is actual, which would combine sufficient effectiveness in the correction of dyslipidemia, taking intoaccount NAFLD stage and the individual tolerability of the drugs in patients with stable coronary heart disease (CHD), combined with NAFLD. Aim. To evaluate the effectiveness of the median-dose statin therapy influence on the lipid profile of the patients with stable coronary heart disease, combined with non-alcoholic fatty liver disease at the stage of steatosis. Material and methods. The subject of the study was 249 patients with stable CHD of II or III functional classes, who had an acute coronary syndrome more than 3 months ago. According to the results of a detailed clinical and diagnostic examination, the patients were divided according to the presence of NAFLD. In particular, among them were 160 patients without NAFLD (Group I) and 89 patients with NAFLD at the stage of steatosis (Group II). The control group consisted of 20 practically healthy persons. General clinical examination, electrocardiography, echocardiography, coronary angiography, evaluation of serum lipid profile were performed to all patients. Results. It was established that the effectiveness of hypolipidemic therapy depended on the presence of NAFLD, the selected statin, its dosage and duration of treatment. In particular, after three months of treatment in patients of Group I, the advantage of hypolipidemic effect of rosuvastatinat a dose 20.0 mg/day vs. atorvastatin at a dose 40.0 mg/day was established. It was shown, that rosuvastatin at a dose 20.0 mg/day caused the achievement of the lipid metabolism target level after 3 months of treatment in 86 (87.8 %) cases with preservation of the hypolipidemic effect within 6 months, compared with atorvastatin at a dose 40.0 mg/day, which was accompanied by the achievement of the target level in 51 (82.3%) cases only aftersix months of therapy in patients with stable CHD without NAFLD. In case of combination with NAFLD at the steatosis stage, there was a significant benefit of prolonged use of rosuvastatin at a dose 20.0 mg/day compared with atorvastatin at a dose of 20.0-40.0 mg/day, which was characterized by a decrease in LDL cholesterol level by 57.7 % after 3 months of treatment and achievement of stable target control of serum lipids profile aftersix months of treatment in 32 (84.2 %) cases. Conclusions. It is expedient to use a long-term statin therapy with rosuvastatin at a dose 20.0 mg/day in order to provide the most effective and stable control of the serum lipid profile, especially in case of combined course with non-alcoholic fatty liver disease at the stage of steatosis in patients with stable coronary heart disease.
Authors and Affiliations
I. Vakalyuk, N. Virstyuk
Keywords
Related Articles
- EP ID EP315705
- DOI 10.25040/lkv2018.01.014
- Views 102
- Downloads 0
Relation between Uric Acid Levels, Creatinine and Body Mass Index in Hypertensive Women and Men
Introduction. Arterial hypertension is taking one of the leading places in the structure of cardiovascular morbidity. As you know, obesity, hypodynamia, excessive intake of food salt, hypercholesterolemia, tobacco smokin...
Особливості перебігу гіпертонічної хвороби у пацієнтів з високим рівнем особистісної тривожності
Вступ. Гіпертонічна хвороба (ГХ) зберігає провідну позицію у списку найбільш поширених захворювань серцево-судинної системи. Відомо, що ГХ часто супроводжується психоемоційними розладами різного ступеня. Мета. Визначення...
State Acid-Base Balance in Patients with Liver Cirrhosis: Role in the Pathogenesis of Respiratory Lesions; Dependence on the Degree of Liver Damage
Introduction. Liver cirrhosis (LC) as a social and medical problem for a long time does not lose its relevance. The main cause of death of the hepatological patients – comorbid syntropic disorders of other organs and sys...
Structural and Functional Changes of the Myocardium in Case of Comorbidity of Postinfarction Cardiosclerosis and Type 2 Diabetes
Introduction. Such diseases as coronary heart disease (CHD) and diabetes mellitus (DM) are common and their prevalence is constantly increasing. The information accumulated in the modern professional literature makes it...
Imbalance of some Trace Elements and their Correction in Alopecia Areata
Іntroduction. Alopecia areata is the most frequent cause of inflammation-induced hair loss, affecting both children and adults and hair of all colors, but historically it has been more prevalent in the younger age groups...